GO:0009749 response to glucose: Cellular Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009749 response to glucose is a biological process defined as any process that results in a change in state or activity of a cell or an organism as a result of a glucose stimulus.
• Glucose sensing and response are critical for metabolic homeostasis, with specialized cells in the pancreas, hypothalamus, and amygdala detecting glucose fluctuations.
• The response to glucose involves rapid changes in gene expression, enzyme production, hormone secretion, and neuronal activity.
• Developmental maturation of glucose responsiveness is essential for proper insulin secretion and metabolic control.
• Dysregulated glucose response contributes to diabetes, obesity, and impaired counterregulatory responses to hypoglycemia.
• CRISPR-based models (knockout, knock-in, overexpression) enable causal dissection of genes mediating the response to glucose.
Description
The response to glucose (GO:0009749) is a fundamental biological process that enables cells and organisms to detect and react to fluctuations in glucose availability. This process encompasses changes in movement, secretion, enzyme production, and gene expression that occur as a result of a glucose stimulus. Glucose is the primary energy substrate for most cells, and the ability to sense and respond to its concentration is essential for metabolic homeostasis, hormone secretion, and neuronal function. Researchers study this process to understand how pancreatic beta cells, hypothalamic neurons, and other glucose-sensing tissues maintain systemic glucose balance and how these mechanisms fail in metabolic diseases. The response to glucose is particularly important in the context of insulin secretion, where glucose acts as both a nutrient and a signal to trigger hormone release. Defects in this response are central to the pathogenesis of diabetes and related metabolic disorders. Understanding the molecular players and regulatory networks involved in GO:0009749 provides a foundation for developing targeted therapeutic strategies and for engineering cell models that recapitulate human metabolic phenotypes.
response to glucose At A Glance
| GO ID | GO:0009749 |
|---|---|
| GO term | response to glucose |
| Ontology | biological_process |
| Synonym | response to glucose stimulus |
| Major function | Detection and reaction to glucose availability, leading to changes in cell state or activity |
| Cellular locations | Pancreatic islets, hypothalamus, amygdala, and other glucose-sensing tissues |
| Key physiological outcomes | Insulin secretion, neuronal activation, hormone release, gene expression changes |
| Related diseases | Diabetes, obesity, hypoglycemia-associated autonomic failure |
| Research methods | Electrophysiology, perifusion, proteomics, CRISPR screening |
What Is GO:0009749?
According to the Gene Ontology, GO:0009749 response to glucose is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus. This broad definition captures the diverse cellular and physiological responses triggered by glucose, ranging from immediate changes in ion channel activity and hormone secretion to long-term alterations in gene expression programs. The term is synonymous with response to glucose stimulus and is classified under the biological_process aspect of the ontology.
Why Is response to glucose Important in Cell Biology?
The response to glucose is essential for life because glucose is the primary energy source for cells and the main regulator of insulin secretion. Dysregulation of this process leads to metabolic diseases such as diabetes, where beta cells fail to respond appropriately to glucose. In the brain, glucose-sensing neurons in the hypothalamus and amygdala modulate counterregulatory responses to hypoglycemia, and their dysfunction can cause dangerous hypoglycemia unawareness. Understanding GO:0009749 is therefore critical for developing therapies that restore proper glucose sensing and response in disease states.
• Glucose is the primary stimulus for insulin secretion from pancreatic beta cells, and defects in this response cause diabetes.
• Hypothalamic glucose-sensing neurons regulate energy balance and counterregulatory hormone release.
• The medial amygdalar nucleus contains glucose-sensing cells that modulate responses to hypoglycemia.
• Developmental maturation of glucose responsiveness is required for neonatal metabolic adaptation.
• Impaired glucose response in islets leads to glucose desensitization and beta cell dysfunction.
• Somatostatin response to glucose is altered by fasting and obesity, linking glucose sensing to broader metabolic regulation.
• Glucose-responsive hydrogels are being developed for diabetic wound repair, highlighting translational applications.
• Proteomic predictors of insulin secretion can identify individuals at risk for beta cell failure.
• CRISPR screens can uncover novel genes regulating the response to glucose.
• Understanding glucose response mechanisms informs dietary and pharmacological interventions for metabolic disease.
What Happens During response to glucose?
Glucose Sensing and Uptake
In simple terms: Cells first need to detect that glucose is present and bring it inside.
The response to glucose begins with glucose sensing, which in pancreatic beta cells involves glucose uptake via GLUT2 transporters and phosphorylation by glucokinase. This initiates a signaling cascade that couples glucose metabolism to insulin secretion. In the brain, glucose-sensing neurons in the hypothalamus and amygdala detect changes in local glucose concentrations through mechanisms that may involve glucose transporters and ion channels. The ability to sense glucose is developmentally regulated, with fetal rat islets acquiring glucose responsiveness in organ culture.
Metabolic and Signaling Cascades
In simple terms: Once inside, glucose is broken down to produce signals that tell the cell to respond.
Glucose metabolism generates ATP, which closes ATP-sensitive potassium channels, depolarizes the cell membrane, and opens voltage-gated calcium channels. The resulting calcium influx triggers insulin granule exocytosis. This process is modulated by cyclic AMP and other second messengers, and impaired cAMP response is associated with glucose desensitization in rat pancreatic islets. In neurons, glucose-induced changes in activity are mediated by ion channel modulation and metabolic signaling.
Hormone Secretion and Neuronal Activation
In simple terms: The cell then releases hormones or changes its electrical activity in response to glucose.
In pancreatic beta cells, the response to glucose culminates in insulin secretion, which is tightly regulated and can be impaired in diabetes. Somatostatin secretion from pancreatic delta cells is also responsive to glucose, and this response is altered by prolonged fasting and obesity. In the brain, glucose-sensing neurons in the ventromedial nucleus of the hypothalamus change their firing rate in response to low glucose, as measured by multi-electrode arrays. The medial amygdalar nucleus modulates counterregulatory responses to hypoglycemia, demonstrating the integration of glucose sensing with systemic hormone release.
Gene Expression and Long-Term Adaptation
In simple terms: Glucose can also change which genes are turned on or off over longer periods.
Beyond acute secretion, the response to glucose involves changes in gene expression that adapt cells to sustained glucose levels. Proteomic studies have identified predictors of individualized insulin secretion, revealing that nutrient-specific responses are shaped by the proteomic landscape of islets. Developmental maturation of glucose responsiveness in human fetal and neonatal islet-like cell clusters involves changes in gene expression programs that enable proper insulin secretion. In glucose-desensitized islets, impaired cAMP response to stimuli reflects altered signaling and gene expression.
Integration with Systemic Metabolism
In simple terms: The response to glucose in one tissue is coordinated with the whole body's metabolic state.
The response to glucose is not cell-autonomous; it is integrated with systemic metabolism through hormones and neuronal circuits. Hypoglycemia triggers counterregulatory responses that are modulated by glucose-sensing regions such as the medial amygdalar nucleus. Somatostatin response to glucose is influenced by nutritional status, as shown by studies in lean and obese non-diabetic subjects before and after prolonged fasting. These systemic interactions ensure that glucose homeostasis is maintained across tissues and conditions.
Key Genes Involved in GO:0009749 response to glucose
The following genes and proteins are central to the response to glucose, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GCK | Glucose phosphorylation, rate-limiting step in glucose sensing | Mutations cause MODY2 and neonatal diabetes; target for CRISPR knock-in models |
| SLC2A2 (GLUT2) | Glucose transporter in beta cells and hepatocytes | Essential for glucose uptake and sensing; knockout models show impaired insulin secretion |
| INS | Insulin hormone | Primary output of glucose response in beta cells; mutations cause diabetes |
| ABCC8 | SUR1 subunit of KATP channel | Regulates insulin secretion in response to glucose; mutations cause congenital hyperinsulinism |
| KCNJ11 | Kir6.2 subunit of KATP channel | Glucose-sensing component; mutations cause neonatal diabetes |
| CACNA1C | Voltage-gated calcium channel | Mediates calcium influx for insulin exocytosis |
| SST | Somatostatin | Glucose-responsive hormone; altered in fasting and obesity |
| PCSK1 | Prohormone convertase 1/3 | Processes proinsulin; mutations cause obesity and diabetes |
| PCSK2 | Prohormone convertase 2 | Processes proinsulin and somatostatin |
| G6PC2 | Glucose-6-phosphatase catalytic subunit 2 | Regulates glucose cycling in beta cells; GWAS locus for fasting glucose |
| SLC30A8 | Zinc transporter ZnT8 | Insulin granule zinc transport; GWAS locus for type 2 diabetes |
| GCGR | Glucagon receptor | Modulates glucose response in liver and islets |
| FFAR1 (GPR40) | Free fatty acid receptor 1 | Potentiates glucose-stimulated insulin secretion |
| GIPR | Gastric inhibitory polypeptide receptor | Incretin receptor enhancing glucose response |
| GLP1R | Glucagon-like peptide-1 receptor | Incretin receptor; target for diabetes drugs |
| SLC16A1 | Monocarboxylate transporter 1 | Regulates pyruvate transport and glucose response in beta cells |
| UCN3 | Urocortin 3 | Marker of mature beta cells and glucose responsiveness |
How Is response to glucose Regulated?
The response to glucose is regulated at multiple levels, including glucose metabolism, ion channel activity, and hormonal feedback. Cyclic AMP signaling is a key modulator; impaired cAMP response to stimuli is observed in glucose-desensitized rat pancreatic islets. Incretin hormones such as GLP-1 and GIP potentiate glucose-stimulated insulin secretion through receptor-mediated cAMP elevation. Systemic factors such as fasting and obesity alter somatostatin response to glucose, indicating nutritional regulation. In the brain, glucose-sensing neurons are regulated by local glucose concentrations and by hormonal signals from the periphery. Developmental maturation of glucose responsiveness involves transcriptional programs that are not fully understood but are critical for neonatal adaptation.
response to glucose and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GCK | MODY2, neonatal diabetes | Knock-in of patient mutations in iPSCs; knockout in beta cell lines |
| ABCC8 | Congenital hyperinsulinism, neonatal diabetes | Point mutation knock-in in INS-1 cells; electrophysiology |
| KCNJ11 | Neonatal diabetes, hyperinsulinism | CRISPR knockout in human islets; patch-clamp |
| INS | Neonatal diabetes, insulinopathy | Knock-in of mutant proinsulin; ER stress assays |
| SLC2A2 | Fanconi-Bickel syndrome | Knockout in hepatocyte-like cells; glucose uptake assays |
Diabetes Mellitus
Dysregulation of the response to glucose is a hallmark of diabetes mellitus. In type 2 diabetes, beta cells become glucose-desensitized, with impaired cAMP response and reduced insulin secretion. Proteomic predictors of insulin secretion can identify individuals with beta cell dysfunction before overt diabetes. Mutations in genes such as GCK, ABCC8, and KCNJ11 cause monogenic forms of diabetes by disrupting glucose sensing and insulin secretion.
Hypoglycemia and Counterregulatory Failure
The brain plays a critical role in counterregulatory responses to hypoglycemia. Glucose-sensing neurons in the ventromedial nucleus of the hypothalamus and the medial amygdalar nucleus modulate hormone release and behavioral responses to low glucose. Dysfunction in these circuits can lead to hypoglycemia unawareness, a dangerous condition in insulin-treated diabetes.
Obesity and Metabolic Syndrome
Obesity alters the response to glucose in multiple tissues. Somatostatin response to glucose is modified by prolonged fasting in obese non-diabetic subjects, suggesting that nutritional status impacts glucose-sensing pathways. Proteomic studies of islets from individuals with obesity reveal nutrient-specific insulin secretion defects.
Diabetic Wound Healing
Glucose-responsive biomaterials are being developed to enhance diabetic wound repair. Hyaluronic acid-based glucose-responsive antioxidant hydrogels improve healing in diabetic wounds by responding to local glucose levels. This illustrates how understanding the response to glucose can inform regenerative medicine.
From response to glucose-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate glucose-stimulated insulin secretion? | CRISPR knockout in pancreatic beta cell lines (INS-1, MIN6) or human iPSC-derived beta cells |
| Does a patient mutation in gene Y alter glucose sensing? | Point mutation knock-in using CRISPR in isogenic cell lines |
| Can a reporter track glucose response in real time? | Knock-in of fluorescent reporter (e.g., GFP) under control of glucose-responsive promoter |
| Does overexpression of gene Z enhance glucose response? | Lentiviral or CRISPR activation overexpression in beta cells |
| Which genes are essential for glucose response in vivo? | CRISPR library screening in mouse models or human islets |
| How does glucose response change during development? | Differentiation of iPSCs into beta-like cells with timed knockout of candidate genes |
How to Study the response to glucose Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Multi-electrode array | Neuronal firing rate changes | Hypothalamic glucose sensing |
| Perifusion | Dynamic hormone secretion | Insulin and somatostatin response to glucose |
| Proteomics | Protein expression and modifications | Predicting insulin secretion capacity |
| Calcium imaging | Intracellular calcium flux | Beta cell glucose response |
| Patch-clamp | Ion channel activity | KATP channel function in glucose sensing |
| CRISPR screen | Gene essentiality for glucose response | Discovery of novel regulators |
| Bioinformatics | Pathway and network analysis | Interpreting omics data from glucose response studies |
Electrophysiology and Live-Cell Imaging
The response to glucose in neurons can be studied using extracellular multi-electrode arrays, which measure changes in neuronal activity in response to low glucose. In beta cells, patch-clamp electrophysiology and calcium imaging reveal ion channel activity and calcium influx during glucose stimulation.
Perifusion and Hormone Secretion Assays
Perifusion of pancreatic islet-like cell clusters allows real-time measurement of insulin and somatostatin secretion in response to glucose. This method has been used to show maturation of insulin response during human fetal and neonatal development and to assess somatostatin response before and after fasting.
Proteomics and Metabolomics
Proteomic profiling of islets can identify predictors of individualized nutrient-specific insulin secretion, linking protein expression to glucose response. Metabolomic approaches complement these by measuring glucose-derived metabolites and signaling molecules.
CRISPR Screening and Functional Genomics
CRISPR library screening enables unbiased discovery of genes required for the response to glucose. Pooled screens in beta cell lines or human islets can identify essential regulators of glucose-stimulated insulin secretion. Bioinformatics analysis of screening data prioritizes candidate genes for follow-up.
How CRISPR Can Be Used to Study GO:0009749 response to glucose
Knockout
CRISPR knockout of candidate genes in beta cell lines or human iPSC-derived islets can determine whether a gene is required for the response to glucose. For example, knocking out SLC2A2 or GCK abolishes glucose-stimulated insulin secretion, confirming their essential roles. Knockout models also help identify genes that are dispensable or redundant.
Point Mutation
Point mutation knock-in using CRISPR allows precise modeling of patient variants in genes such as ABCC8 or KCNJ11. These models can reveal how specific mutations alter glucose sensing and insulin secretion, as seen in congenital hyperinsulinism and neonatal diabetes. Isogenic cell lines with single-nucleotide changes provide controlled comparisons.
Knock-in
Knock-in of reporter genes or tagged proteins enables real-time monitoring of glucose response. For example, inserting a fluorescent reporter under the control of an insulin promoter allows tracking of beta cell activation by glucose. Knock-in of epitope tags facilitates proteomic analysis of glucose-responsive complexes.
Overexpression
CRISPR activation or lentiviral overexpression can test whether increasing a gene's activity enhances or dampens the response to glucose. Overexpression of GCK or SLC2A2 in beta cells increases glucose sensitivity, while overexpression of negative regulators blunts it. These models are useful for validating gain-of-function hypotheses.
How EDITGENE Supports response to glucose Research
Researchers studying response to glucose-related genes often need to determine whether a candidate gene is causally involved in glucose sensing, insulin secretion, or neuronal activation. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for response to glucose research.
Frequently Asked Questions About response to glucose
What is GO:0009749 response to glucose?
GO:0009749 is a Gene Ontology biological process term defined as any process that results in a change in state or activity of a cell or an organism as a result of a glucose stimulus.
What genes are involved in response to glucose?
Key genes include GCK, SLC2A2, INS, ABCC8, KCNJ11, and SST, among others.
How is response to glucose measured?
Methods include perifusion for hormone secretion, multi-electrode arrays for neuronal activity, proteomics, and calcium imaging.
What diseases are associated with impaired response to glucose?
Diabetes, obesity, hypoglycemia unawareness, and metabolic syndrome are linked to defects in glucose response.
What is the role of the hypothalamus in response to glucose?
Hypothalamic neurons, such as those in the ventromedial nucleus, sense low glucose and modulate counterregulatory responses.
How does glucose trigger insulin secretion?
Glucose metabolism increases ATP, closes KATP channels, depolarizes the membrane, and triggers calcium influx and insulin exocytosis.
Can CRISPR be used to study response to glucose?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in glucose-responsive cells.
What is the difference between response to glucose and glucose homeostasis?
Response to glucose refers to cellular reactions to a glucose stimulus, while glucose homeostasis is the systemic maintenance of blood glucose levels.
Why is developmental maturation of glucose response important?
Fetal and neonatal islets must acquire glucose responsiveness for proper insulin secretion after birth.
How does fasting affect somatostatin response to glucose?
Prolonged fasting alters somatostatin response to glucose in lean and obese subjects, indicating nutritional regulation.
Conclusion
The response to glucose (GO:0009749) is a central biological process that integrates glucose sensing with hormone secretion, neuronal activity, and gene expression. Its dysregulation underlies major metabolic diseases, making it a prime target for research and therapeutic development. Advances in CRISPR modeling and proteomics are accelerating the discovery of causal genes and pathways, offering new hope for personalized interventions in diabetes and related disorders.
References
- 1. Xu Z et al.. 2022. Hyaluronic acid-based glucose-responsive antioxidant hydrogel platform for enhanced diabetic wound repair.. Acta Biomater 147:147-157 PMID: 35649507
- 2. Hanna L et al.. 2020. Changes in neuronal activity across the mouse ventromedial nucleus of the hypothalamus in response to low glucose: Evaluation using an extracellular multi-electrode array approach.. J Neuroendocrinol 32(3):e12824 PMID: 31880369
- 3. Kaung HL et al.. 1975. Development of response to glucose of fetal rat islet in organ culture (38479).. Proc Soc Exp Biol Med 148(1):75-9 PMID: 1093188
- 4. Otonkoski T et al.. 1988. Maturation of insulin response to glucose during human fetal and neonatal development. Studies with perifusion of pancreatic isletlike cell clusters.. Diabetes 37(3):286-91 PMID: 3286329
- 5. Kolic J et al.. 2024. Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease.. Cell Metab 36(7):1619-1633.e5 PMID: 38959864
- 6. Zhou L et al.. 2010. The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia.. Diabetes 59(10):2646-52 PMID: 20627933
- 7. Laychock SG. 1995. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.. Mol Cell Endocrinol 113(1):19-28 PMID: 8674810
- 8. Verrillo A et al.. 1988. Somatostatin response to glucose before and after prolonged fasting in lean and obese non-diabetic subjects.. Regul Pept 21(3-4):185-95 PMID: 2901133
